<DOC>
	<DOCNO>NCT01583465</DOCNO>
	<brief_summary>The purpose study establish whether clinical advantage use Aquamantys® System Medtronic Advanced Energy ( formerly Salient Surgical Technologies ) patient undergo primary total hip arthroplasty via anterior supine intermuscular surgical approach term blood loss , transfusion wound heal . Wound heal assess blind observer base upon simple subjective criterion : ) expect , b ) well expect c ) worse expect . The blind observer experience care surgical patient wound evaluation .</brief_summary>
	<brief_title>Efficacy Aquamantys Reducing Transfusions With Anterior Supine Intermuscular Approach Total Hip Arthroplasty</brief_title>
	<detailed_description>To establish randomize , blind study whether clinical advantage use Aquamantys® System Medtronic Advanced Energy ( formerly Salient Surgical Technologies ) patient undergo primary total hip arthroplasty via anterior supine intermuscular surgical approach term blood loss , transfusion wound heal base early collect data . Data analyze use StatsDirect standard fashion elucidate difference control treatment group . Wound heal assess blind observer base upon simple subjective criterion : ) expect , b ) well expect c ) worse expect . The blind observer experience care surgical patient wound evaluation .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Dislocations</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Osteoarthritis , Hip</mesh_term>
	<mesh_term>Osteonecrosis</mesh_term>
	<mesh_term>Hip Dislocation</mesh_term>
	<mesh_term>Joint Deformities , Acquired</mesh_term>
	<mesh_term>Hip Dislocation , Congenital</mesh_term>
	<criteria>Undergoing primary unilateral total hip arthroplasty via anterior supine intermuscular approach Patient willing able complete followup visit 6 week 1 year Patients preexist know coagulopathy Patients chronic Coumadin ( Warfarin ) therapy Patients receive erythropoietin therapy anemia</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>randomize control trial</keyword>
	<keyword>Blood loss , surgical</keyword>
	<keyword>Blood loss , postoperative</keyword>
	<keyword>Wound heal</keyword>
</DOC>